Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer. (Q54762579)

3 June 2018

title

Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer. (English)

1 reference

3 June 2018

main subject

cervix uterine cancer

1 reference

Tessy T Maliekal

1

1 reference

3 June 2018

Marie-Lue Antony

2

1 reference

3 June 2018

Asha Nair

3

1 reference

3 June 2018

Ramasamy Paulmurugan

4

1 reference

3 June 2018

Devarajan Karunagaran

5

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 June 2018

published in

Oncogene

1 reference

3 June 2018

volume

22

1 reference

3 June 2018

issue

31

1 reference

3 June 2018

page(s)

4889-4897

1 reference

3 June 2018

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

Role of transforming growth factor-beta signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

The Bethesda system and evaluation of abnormal pap smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

Epidemiology and biology of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

Signal transduction by the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Preventing cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Frequent loss of SMAD4/DPC4 protein in colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206806

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206806

1 reference

3 June 2018

1 reference

3 June 2018